| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.28 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |